These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 22187097)

  • 21. The prevalence of thrombophilia and venous thromboembolism in total knee arthroplasty.
    Chotanaphuti T; Ongnamthip P; Silpipat S; Foojareonyos T; Roschan S; Reumthantong A
    J Med Assoc Thai; 2007 Jul; 90(7):1342-7. PubMed ID: 17710975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery.
    Wåhlander K; Larson G; Lindahl TL; Andersson C; Frison L; Gustafsson D; Bylock A; Eriksson BI
    Thromb Haemost; 2002 Apr; 87(4):580-5. PubMed ID: 12008938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Venous thromboembolic disease after total hip and knee arthroplasty: current perspectives in a regulated environment.
    Pellegrini VD; Sharrock NE; Paiement GD; Morris R; Warwick DJ
    Instr Course Lect; 2008; 57():637-61. PubMed ID: 18399613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Warfarin prophylaxis in patients after total knee or hip arthroplasty--international normalized ratio patterns and venous thromboembolism.
    Nordstrom BL; Kachroo S; Fraeman KH; Nutescu EA; Schein JR; Fisher A; Bookhart BK
    Curr Med Res Opin; 2011 Oct; 27(10):1973-85. PubMed ID: 21919556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased one-year risk of symptomatic venous thromboembolism following total hip replacement: a nationwide cohort study.
    Pedersen AB; Johnsen SP; Sørensen HT
    J Bone Joint Surg Br; 2012 Dec; 94(12):1598-603. PubMed ID: 23188898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Symptomatic venous thromboembolism in elderly patients following major orthopedic surgery of the lower limb is associated with elevated vitamin B12 serum levels.
    Grossfeld A; Dekel S; Lerman Y; Sherman S; Atzmony L; Salai M; Justo D
    Clin Biochem; 2013 Jan; 46(1-2):54-8. PubMed ID: 23000313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors and distribution of symptomatic venous thromboembolism in total hip and knee replacements: prospective study.
    Markovic-Denic L; Zivkovic K; Lesic A; Bumbasirevic V; Dubljanin-Raspopovic E; Bumbasirevic M
    Int Orthop; 2012 Jun; 36(6):1299-305. PubMed ID: 22215369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of postoperative venous thromboembolism on Medicare recipients undergoing total hip replacement or total knee replacement surgery.
    Baser O; Supina D; Sengupta N; Wang L; Kwong L
    Am J Health Syst Pharm; 2010 Sep; 67(17):1438-45. PubMed ID: 20720243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
    Haentjens P; De Groote K; Annemans L
    Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of symptomatic venous thromboembolism associated with flying in the early postoperative period following elective total hip and knee arthroplasty.
    Cooper HJ; Sanders SA; Berger RA
    J Arthroplasty; 2014 Jun; 29(6):1119-22. PubMed ID: 24556112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Economic impact of venous thromboembolism after hip and knee arthroplasty: potential impact of rivaroxaban.
    Friedman RJ; Sengupta N; Lees M
    Expert Rev Pharmacoecon Outcomes Res; 2011 Jun; 11(3):299-306. PubMed ID: 21671699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enoxaparin versus dabigatran or rivaroxaban for thromboprophylaxis after hip or knee arthroplasty: Results of separate pooled analyses of phase III multicenter randomized trials.
    Huisman MV; Quinlan DJ; Dahl OE; Schulman S
    Circ Cardiovasc Qual Outcomes; 2010 Nov; 3(6):652-60. PubMed ID: 20923996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and economic burden of venous thromboembolism after total hip arthroplasty or total knee arthroplasty.
    Baser O
    Am J Manag Care; 2011 Feb; 17(1 Suppl):S6-8. PubMed ID: 21517654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose-escalation study of rivaroxaban (BAY 59-7939)--an oral, direct Factor Xa inhibitor--for the prevention of venous thromboembolism in patients undergoing total hip replacement.
    Eriksson BI; Borris LC; Dahl OE; Haas S; Huisman MV; Kakkar AK; Misselwitz F; Muehlhofer E; Kälebo P
    Thromb Res; 2007; 120(5):685-93. PubMed ID: 17292948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Occult Left Common Iliac Vein Compression Increases Postoperative Venous Thromboembolism Risk Following Total Hip Arthroplasty.
    Bergen MA; Wall KC; Kim CY; Garrigues GE
    J Arthroplasty; 2019 Feb; 34(2):375-378. PubMed ID: 30448323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Duration of anesthesia and venous thromboembolism after hip and knee arthroplasty.
    Jaffer AK; Barsoum WK; Krebs V; Hurbanek JG; Morra N; Brotman DJ
    Mayo Clin Proc; 2005 Jun; 80(6):732-8. PubMed ID: 15945526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thromboprophylaxis following hip and knee arthroplasty.
    Mirkazemi C; Bereznicki LR; Peterson GM
    Intern Med J; 2013 Feb; 43(2):124-9. PubMed ID: 23402484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Influence of body mass index and age on deep vein thrombosis after total hip and knee arthroplasty].
    Guan Z; Chen Y; Song Y
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Jun; 20(6):611-5. PubMed ID: 16827383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dabigatran is effective with a favourable safety profile in normal and overweight patients undergoing major orthopaedic surgery: a pooled analysis.
    Eriksson BI; Dahl OE; Feuring M; Clemens A; Noack H; Hantel S; Friedman RJ; Huo M
    Thromb Res; 2012 Nov; 130(5):818-20. PubMed ID: 22840686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-dose warfarin for prevention of symptomatic thromboembolism after orthopedic surgery.
    Enyart JJ; Jones RJ
    Ann Pharmacother; 2005 Jun; 39(6):1002-7. PubMed ID: 15886295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.